WASHINGTON, March 12 -- Law firms assisted companies in the following recently announced transactions - March 12, 2026: * * * Arnold & Porter advised Corstasis Therapeutics in its agreement to be acquired by Esperion Therapeutics. The transaction includes an upfront cash payment of $75 million and potential milestone payments totaling up to $180 million, along with royalties tied to future product sales. The acquisition is expected to close in the second quarter of 2026 subject to customary cl more ST